Biosensors for Monitoring Peri-Implantitis: Current Status and Future Directions

Abstract

Peri-implantitis, an inflammatory disease affecting the tissues surrounding dental implants, poses a significant challenge to long-term implant success. Early detection and monitoring of peri-implantitis are crucial for effective treatment and prevention of implant failure. Traditional diagnostic methods, such as clinical examination and radiographic imaging, often lack the sensitivity and specificity for early detection. Biosensors offer a promising alternative for real-time, continuous monitoring of peri-implant health by detecting specific biomarkers associated with inflammation and tissue destruction. This paper reviews the current status of biosensors for peri-implantitis monitoring, focusing on the types of biosensors developed, the biomarkers they target, and their clinical applications. We also discuss the challenges and future directions in the development of advanced biosensors for early diagnosis and personalized management of peri-implantitis.

Keywords: Peri-implantitis, Biosensors, Biomarkers, Diagnosis, Monitoring, Dental implants

Introduction

Dental implants have become a cornerstone of modern dentistry, offering a reliable and effective solution for replacing missing teeth and restoring oral function and aesthetics. The success of dental implants relies on achieving and maintaining osseointegration, a process where the implant integrates directly with the surrounding bone tissue. While dental implants boast high success rates, peri-implantitis, an inflammatory condition affecting the soft and hard tissues surrounding the implant, represents a significant threat to long-term implant stability and longevity. Peri-implantitis can lead to progressive bone loss, soft tissue inflammation [1-7], and ultimately, implant failure if left untreated. The prevalence of peri-implantitis is estimated to range from 10% to 20%, making it a critical concern [8-12] for both clinicians and patients. Therefore, effective strategies for early detection, accurate diagnosis, and per sonalized management of peri-implantitis are essential for ensuring the long-term success of dental implants.

Traditional diagnostic methods for peri-implantitis primarily rely on clinical examination, including probing depth measurements, assessment of bleeding on probing, and evaluation of soft tissue inflammation. Radiographic imaging, such as periapical radiographs and Cone-Beam Computed Tomography (CBCT), is also employed to assess bone levels and detect bone loss around the implant. While these methods provide valuable information, they often have limitations in detecting early stages of peri-implantitis. Clinical examination can be subjective and may not capture subtle changes in soft tissue health. Radiographic imaging, while essential for assessing bone loss, may not reveal early inflammatory processes occurring in the soft tissues. Furthermore, these methods typically provide a snapshot of the peri-implant condition at a specific point in time, lacking the ability to continuously monitor the dynamic nature of the inflammatory process.

The pathogenesis of peri-implantitis is complex and involves a complex interplay of factors, including bacterial biofilm formation, host immune response, and biomechanical factors. Bacterial colonization on the implant surface is considered the primary etiological factor, leading to the release of inflammatory mediators that trigger a cascade of events resulting in tissue destruction. The host’s immune response plays a crucial role in modulating the inflammatory process, and variations in individual susceptibility can influence the progression of peri-implantitis. Biomechanical factors, such as implant design, surgical technique, and occlusal loading, can also contribute to the development and progression of the disease. Understanding the complex interplay of these factors is crucial for developing effective diagnostic and therapeutic strategies. Given the limitations of traditional diagnostic methods, there is a growing need for innovative approaches that can provide early, accurate, and continuous monitoring of peri-implant health. In recent years, significant advancements have been made in the development of biosensors for various medical applications, including the detection and monitoring of infectious diseases, cancer, and other health conditions [5]. Biosensors offer a promising alternative for peri-implantitis monitoring by enabling the detection of specific biomarkers associated with inflammation and tissue destruction. These biomarkers can include inflammatory cytokines, enzymes, and other molecules released during the peri-implantitis process. By continuously monitoring the levels of these biomarkers, biosensors can provide real-time information about the peri-implant condition, allowing for early detection of subtle changes and timely intervention.

Biosensors utilize a variety of sensing mechanisms, including electrochemical, optical, and piezoelectric methods, to detect and quantify target biomarkers. Electrochemical biosensors, for example, measure changes in electrical current or potential resulting from the interaction between the biomarker and a sensing element. Optical biosensors [13-17] utilize changes in light absorbance, fluorescence, or reflectance to detect biomarkers. Piezoelectric biosensors measure changes in the frequency of a crystal oscillator due to the binding of biomarkers to the sensor surface. The choice of sensing mechanism depends on the specific biomarker being targeted and the desired sensitivity and specificity of the biosensor.

This paper provides a comprehensive review of the current status of biosensors for peri-implantitis monitoring. We will discuss the different types of biosensors that have been developed, the specific biomarkers they target, and their potential clinical applications. We will also examine the challenges and limitations associated with the use of biosensors in peri-implantitis diagnosis and monitoring. Finally, we will explore future directions in the development of advanced biosensors, including the integration of nanotechnology, microfluidics, and artificial intelligence, for improved early diagnosis, personalized management, and ultimately, enhanced long-term success of dental implants. By providing a comprehensive overview of this rapidly evolving field, we aim to highlight the potential of biosensors to revolutionize peri-implantitis management and contribute to improved patient outcomes.

Challenges

While biosensors hold immense promise for revolutionizing peri-implantitis management, several significant challenges remain in their development and translation into clinical practice. Addressing these challenges is crucial for realizing the full potential of biosensors for early diagnosis and personalized treatment of peri-implantitis.

Biomarker Selection and Specificity

Identifying and validating appropriate biomarkers for peri-implantitis is a critical challenge. Ideally, biomarkers should be highly specific to peri-implantitis, reflecting the disease’s activity and progression, while being minimally influenced by other factors such as systemic inflammation or oral microbiome variations. Currently, several potential biomarkers, including inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6), Matrix Metalloproteinases (MMPs), and bone turnover markers, are being investigated [1]. However, the complex interplay of these biomarkers in the peri-implant environment and their correlation with different stages of peri-implantitis requires further investigation. Furthermore, the presence of similar biomarkers in other oral diseases, such as periodontitis, necessitates careful selection and validation of biomarkers that can differentiate between these conditions.

Sensitivity and Selectivity

Biosensors for peri-implantitis monitoring must possess high sensitivity to detect low concentrations of target biomarkers in the peri-implant [18-20] Crevicular Fluid (PICF) or surrounding tissues. The PICF volume is typically small, and the concentrations of biomarkers can be very low, requiring highly sensitive detection methods. Simultaneously, the biosensor must exhibit high selectivity to avoid interference from other molecules present in the PICF, such as proteins, enzymes, and other inflammatory mediators. Achieving both high sensitivity and selectivity is a significant technical challenge.

Biocompatibility and Biofouling

Biosensors intended for in vivo or long-term monitoring must be biocompatible to avoid adverse reactions in the surrounding tissues. The materials used in the biosensor should not elicit an inflammatory response or interfere with the healing process. Furthermore, biofouling, the accumulation of proteins and other biomolecules on the sensor surface, can significantly hinder the performance of biosensors by reducing their sensitivity and selectivity. Strategies to minimize biofouling, such as surface modification or the use of anti-fouling coatings, are essential for developing reliable biosensors.

Miniaturization and Integration

For practical applications, biosensors for peri-implantitis monitoring need to be miniaturized and integrated into a user-friendly format. Ideally, the biosensor should be easily incorporated into existing dental devices or implants, allowing for seamless and continuous monitoring of the peri-implant environment. Developing miniaturized biosensors that maintain high performance and stability is a significant engineering challenge. Furthermore, integrating the biosensor with a signal processing unit and a data transmission system for real-time monitoring and data analysis is crucial for clinical utility.

Long-Term Stability and Reliability

Biosensors for peri-implantitis monitoring should exhibit longterm stability and reliability to provide continuous and accurate data over extended periods. The sensor’s performance should not degrade over time due to factors such as material degradation, biofouling, or changes in the surrounding environment. Ensuring the long-term stability and reliability of biosensors is crucial for their clinical applicability.

Clinical Validation and Regulatory Approval

Before biosensors can be widely adopted in clinical practice, they must undergo rigorous clinical validation to demonstrate their safety and efficacy. Clinical trials are necessary to evaluate the performance of the biosensor in real-world settings and to compare its diagnostic accuracy with existing methods. Furthermore, regulatory approval from relevant authorities is required before biosensors can be marketed and used in clinical practice.

Cost-Effectiveness

The cost of biosensor development, manufacturing, and implementation is an important consideration. To ensure widespread adoption, biosensors for peri-implantitis [21-24] monitoring should be cost-effective compared to existing diagnostic methods. Reducing the cost of biosensor technology without compromising its performance is a significant challenge.

Data Management and Interpretation

The continuous monitoring of peri-implant health using biosensors generates large amounts of data. Effective data management and interpretation are essential for translating this data into clinically useful information. Developing algorithms and software tools for analyzing and interpreting biosensor data is crucial for providing clinicians with actionable insights.

Benefits of Biosensors for Peri-Implantitis Monitoring

Despite the challenges in their development, biosensors offer a multitude of potential benefits for peri-implantitis monitoring, promising to revolutionize the way this condition is diagnosed and managed. These advantages stem from their ability to provide real- time, continuous, and highly sensitive detection of biomarkers associated with peri-implantitis, leading to improved patient outcomes and long-term implant success.

Early Detection and Prevention

One of the most significant benefits of biosensors is their potential for early detection of peri-implantitis. By continuously monitoring biomarker levels, biosensors can detect subtle changes in the peri-implant environment before clinical symptoms become apparent. This allows for timely intervention and preventative measures, potentially halting the progression of the disease and preventing irreversible damage to the supporting tissues. Early detection can significantly improve the prognosis of peri-implantitis and reduce the risk of implant failure.

Continuous Monitoring and Personalized Treatment

Traditional diagnostic methods provide a snapshot of the peri-implant condition at a specific point in time. Biosensors, on the other hand, offer continuous monitoring, providing a dynamic picture of the inflammatory process. This continuous data stream allows clinicians to track the progression of peri-implantitis over time and to personalize treatment strategies based on individual patient responses. Real-time feedback on the effectiveness of treatment can enable adjustments to the treatment plan, leading to more optimized and personalized care.

Objective and Quantitative Assessment

Unlike clinical examination, which can be subjective, biosensors provide objective and quantitative measurements of biomarker levels. This eliminates inter-examiner variability and allows for more accurate and consistent assessment of the peri-implant condition. Quantitative data can also be used to track treatment outcomes and to compare the effectiveness of different treatment modalities.

Minimally Invasive or Non-Invasive Monitoring

Depending on the design and placement of the biosensor, monitoring can be minimally invasive or even non-invasive. This reduces patient discomfort and the risk of complications associated with more invasive procedures. For example, biosensors integrated into the implant itself or placed in the peri-implant crevicular fluid can provide valuable information without requiring additional surgical intervention.

Improved Diagnostic Accuracy

Biosensors targeting specific biomarkers can offer improved diagnostic [25-27] accuracy compared to traditional methods. By detecting changes in biomarker levels that precede clinical signs, biosensors can potentially identify peri-implantitis at an earlier stage, when treatment is more likely to be successful. This can lead to a reduction in false negatives and improved overall diagnostic accuracy.

Enhanced Patient Compliance and Engagement

The ability to monitor peri-implant health continuously can enhance patient compliance with maintenance protocols. Real-time feedback on the peri-implant condition can motivate patients to adhere to oral hygiene instructions and to attend regular check-ups. Furthermore, patients can be actively involved in monitoring their own peri-implant health through the use of wearable or portable biosensor devices, fostering greater engagement in their care.

Potential For Remote Monitoring and Telemedicine

Biosensor data can be transmitted wirelessly to a central database, allowing for remote monitoring of patients. This is particularly beneficial for patients who have limited access to dental care or who require frequent monitoring. Remote monitoring can also facilitate timely intervention and reduce the need for in-person visits, improving efficiency and reducing healthcare costs.

Development of New Therapeutic Strategies

The data generated by biosensors can provide valuable insights into the pathogenesis of peri-implantitis and the mechanisms of action of different treatments. This information can be used to develop new and more effective therapeutic strategies targeted at specific biomarkers or pathways involved in the disease process.

Cost-Effectiveness in the Long Term

While the initial cost of biosensor technology may be higher than traditional methods, the long-term benefits can lead to cost savings. Early detection and prevention of peri-implantitis can reduce the need for more extensive and costly treatments, such as implant removal or bone grafting. Furthermore, remote monitoring and reduced need for in-person visits can also contribute to cost savings over time.

Advantages and Disadvantages of Biosensors for Peri-Implantitis Monitoring

Biosensors hold significant promise for improving peri-implantitis management [28-30], but like any technology, they come with their own set of advantages and disadvantages. A balanced understanding of these aspects is crucial for guiding research, development, and clinical implementation.

Advantages

Early Detection: Detects subtle changes in biomarker levels before clinical symptoms appear, enabling timely intervention and potentially preventing irreversible damage.

Continuous Monitoring: Provides real-time, dynamic data on the inflammatory process, allowing for personalized treatment and tracking of treatment effectiveness.

Objective and Quantitative Assessment: Offers objective measurements of biomarker levels, eliminating subjectivity and improving diagnostic accuracy.

Minimally Invasive/Non-Invasive: Depending on the design, monitoring can be minimally invasive or non-invasive, reducing patient discomfort and risk.

Improved Diagnostic Accuracy: Targets specific biomarkers, potentially leading to earlier and more accurate diagnosis compared to traditional methods.

Enhanced Patient Compliance: Real-time feedback can motivate patients to adhere to oral hygiene and maintenance protocols. Potential for Remote Monitoring: Enables remote monitoring and telemedicine, especially beneficial for patients with limited access to care.

Development of New Therapies: Data can provide insights into peri-implantitis pathogenesis and inform the development of new treatment strategies.

Long-Term Cost-Effectiveness: Early detection and prevention can reduce the need for more extensive and costly treatments.

Personalized Medicine: Enables tailored treatment plans based on individual patient responses and biomarker profiles.

Disadvantages

Biomarker Selection and Specificity: Difficulty in identifying and validating biomarkers highly specific to peri-implantitis, with minimal influence from other factors.

Sensitivity and Selectivity: Challenges in achieving both high sensitivity (detecting low biomarker concentrations) and selectivity (avoiding interference from other molecules).

Biocompatibility and Biofouling: Concerns about biocompatibility of sensor materials and the potential for biofouling to hinder sensor performance.

Miniaturization and Integration: Difficulty in miniaturizing sensors and integrating them into user-friendly formats, especially within existing dental devices.

Long-Term Stability and Reliability: Challenges in ensuring long-term stability and reliability of sensor performance over extended periods in the oral environment.

Clinical Validation and Regulatory Approval: Need for rigorous clinical trials and regulatory approval before widespread clinical use.

Cost-Effectiveness (Initial): Initial cost of biosensor technology may be higher than traditional methods, although long-term benefits can lead to cost savings.

Data Management and Interpretation: Need for effective data management and interpretation tools to translate raw data into clinically actionable insights.

Technical Complexity: Development and manufacturing of biosensors require specialized expertise and advanced technology.

Potential for Sensor Failure: Like any electronic device, biosensors can malfunction or fail, requiring replacement or repair.

Patient Acceptance: Patient acceptance of wearable or implantable biosensors may vary.

Ethical Considerations: Concerns about data privacy and security related to continuous monitoring data.

Future Directions and Research Opportunities for Biosensors in Peri-Implantitis Monitoring

The field of biosensors for peri-implantitis monitoring is rapidly evolving, with numerous research opportunities and future directions that promise to enhance the diagnosis, treatment, and long-term management of this challenging condition. These advancements aim to overcome current limitations and unlock the full potential of biosensor technology.

Advanced Biomarker Discovery and Validation

Continued research is needed to identify and validate novel biomarkers that are highly specific to peri-implantitis, reflect disease activity and progression, and are minimally influenced by other factors. Exploring a panel of biomarkers rather than relying on a single marker may provide a more comprehensive picture of the peri-implant environment. Furthermore, investigating the correlation between biomarker levels and different stages of peri-implantitis is crucial for developing accurate diagnostic algorithms.

Development Of Highly Sensitive and Selective Biosensors

Future biosensors should exhibit improved sensitivity to detect low biomarker concentrations in the PICF and enhanced selectivity to minimize interference from other molecules. Nanomaterials, such as graphene, carbon nanotubes, and metal nanoparticles, offer promising avenues for enhancing the sensitivity and selectivity of biosensors. Microfluidic devices can also be integrated with biosensors to precisely control fluid flow and improve detection limits.

Integration of Artificial Intelligence and Machine Learning

Integrating Artificial Intelligence (AI) and Machine Learning [31,32] (ML) algorithms with biosensor data analysis can revolutionize peri-implantitis monitoring. AI/ML can be used to analyze complex datasets, identify patterns and trends, and predict the risk of peri-implantitis progression. These tools can also assist clinicians in making more informed treatment decisions and personalizing patient care.

Miniaturization and Wireless Integration

Further miniaturization of biosensors and their seamless integration into dental implants, prosthetics, or other intraoral devices are essential for practical applications. Wireless communication technologies, such as Bluetooth or Near-Field Communication (NFC), can enable real-time data transmission and remote monitoring. Developing self-powered or energy-harvesting biosensors can eliminate the need for battery replacement and enhance long-term monitoring capabilities.

Development of Smart Implants and Personalized Monitoring Systems

The concept of “smart implants” equipped with integrated biosensors holds great promise for personalized peri-implantitis management. These smart implants can continuously monitor the peri-implant environment and provide real-time feedback to both clinicians and patients. Developing personalized monitoring systems that integrate data from multiple sources, such as biosensors, clinical records, and patient-reported outcomes, can further enhance the precision and effectiveness of peri-implantitis care.

Long-Term Stability and Biocompatibility

Improving the long-term stability and biocompatibility of biosensors is crucial for their clinical applicability. Research efforts should focus on developing novel biomaterials and surface modifications that resist biofouling and minimize adverse tissue reactions. Encapsulating the sensor components in biocompatible materials can also enhance their durability and protect them from the harsh oral environment.

Clinical Validation and Translation

Rigorous clinical trials are necessary to validate the safety and efficacy of biosensors for peri-implantitis monitoring. These studies should evaluate the performance of the biosensor in real-world settings and compare its diagnostic accuracy with existing methods. Translating promising biosensor technologies from the laboratory to the clinic requires collaboration between researchers, clinicians, and industry partners.

Focus on Patient-Centric Design

Future biosensor development should prioritize patient-centric design, ensuring that the devices are easy to use, comfortable, and acceptable to patients. Developing user-friendly interfaces and data visualization tools can empower patients to actively participate in their care and improve adherence to maintenance protocols.

Addressing Ethical Considerations

As biosensor technology advances, it is essential to address ethical considerations related to data privacy, security, and informed consent. Clear guidelines and regulations are needed to ensure responsible use of biosensor data and protect patient confidentiality.

Cost-Effective Manufacturing and Scalability

Developing cost-effective manufacturing methods for biosensors is crucial for their widespread adoption. Scalable production processes are necessary to reduce the cost of biosensor technology and make it accessible to a larger patient population.

Conclusion

In conclusion, peri-implantitis poses a significant challenge to the long-term success of dental implants, necessitating improved diagnostic and monitoring strategies. This review has highlighted the immense potential of biosensors to revolutionize peri-implantitis management by offering real-time, continuous, and highly sensitive detection of disease-related biomarkers. While traditional diagnostic methods often fall short in detecting early stages of the disease, biosensors offer the promise of early detection, personalized treatment, and ultimately, improved patient outcomes.

We have discussed the various types of biosensors being developed, their target biomarkers, and the sensing mechanisms employed. The advantages of biosensors, including their ability to provide objective, quantitative data and enable minimally invasive monitoring, have been emphasized. However, we have also acknowledged the significant challenges that remain, such as biomarker selection, sensitivity and selectivity issues, biocompatibility concerns, and the need for miniaturization and integration. These challenges underscore the complexity of developing reliable and clinically applicable biosensors for peri-implantitis monitoring.

Acknowledgements

None.

Conflict of Interests

None.

References

• Panahi P, Bayılmış C, Çavuşoğlu U, Kaçar S (2021) Performance evaluation of lightweight encryption algorithms for IoT-based applications. Arabian Journal for Science and Engineering 46(4): 4015-4037.
• Panahi U, Bayılmış C (2023) Enabling secure data transmission for wireless sensor networks based IoT applications. Ain Shams Engineering Journal 14(2): 101866.
• Omid Panahi, Mohammad Zeinalddin (2024) The Remote Monitoring Toothbrush for Early Cavity Detection using Artificial Intelligence (AI). IJDSIR 7(4): 173 -178.
• Omid Panahi, Reza Safaralizadeh (2024) AI and Dental Tissue Engineering: A Potential Powerhouse for Regeneration. Mod Res Dent 8(2): 000682.
• Omid Panahi (2024) Dental Implants & the Rise of AI. On J Dent & Oral Health 8(1): OJDOH.MS.ID.000679.
• Panahi O (2024) The Rising Tide: Artificial Intelligence Reshaping Healthcare Management. S J Publc Hlth 1(1): 1-3.
• Panahi O, Zeinalddin M (2024) The Convergence of Precision Medicine and Dentistry: An AI and Robotics Perspective. Austin J Dent 11(2): 1186.
• Omid Panahi, Uras Panahi (2025) AI-Powered IoT: Transforming Diagnostics and Treatment Planning in Oral Implantology. J Adv Artif Intell Mach Learn 1(1): 1-4.
• Panahi P (2008) Multipath Local Error Management Technique Over Ad Hoc Networks. In 2008 International Conference on Automated Solutions for Cross Media Content and Multi-Channel Distribution 187-194.
• Panahi P (2009) Providing consistent global sharing service over VANET using new plan. In 2009 14th International CSI Computer Conference 213-218.
• Omid Panahi, Sevil Farrokh (2024) USAG-1-Based Therapies: A Paradigm Shift in Dental Medicine. Int J Nurs Health Care 1(1): 1-4.
• Omid Panahi, Sevil Farrokh (2024) Can AI Heal Us? The Promise of AI-Driven Tissue Engineering. Int J Nurs Health Care 1(1): 1-4.
• Koyuncu B, Gokce A, Panahi P (2015) Reconstruction of an Archeological site in real time domain by using software techniques. In 2015 Fifth International Conference on Communication Systems and Network Technologies 1350-1354.
• Panahi P, Dehghan M (2008) Multipath Video Transmission Over Ad Hoc Networks Using Layer Coding and Video Caches. In ICEE2008, 16th Iranian Conference on Electrical Engineering 50-55.
• Panahi P, Maragheh HK, Abdolzadeh M, Sharifi M (2008) A novel schema for multipath video transferring over ad hoc networks. In 2008 The Second International Conference on Mobile Ubiquitous Computing, Systems, Services and Technologies 77-82.
• Panahi P, Bayılmış C (2017) Car indoor gas detection system. In 2017 International Conference on Computer Science and Engineering (UBMK) 957-960.
• Panahi P (2010) The feedback based mechanism for video streaming over multipath ad hoc networks. Journal of Sciences Islamic Republic of Iran 21(2).
• Panahi O, Zeinaldin M (2024) Digital Dentistry: Revolutionizing Dental Care. J Dent App 10 (1): 1121.
• Panahi O (2024) AI in Surgical Robotics: Case Studies. Austin J Clin Case Rep 11(7): 1342.
• Panahi O, Zeinaldin M (2024) AI-Assisted Detection of Oral Cancer: A Comparative Analysis. Austin J Pathol Lab Med 10 (1): 1037.
• Omid P, Reza S (2024) How Artificial Intelligence and Biotechnology are Transforming Dentistry. Adv Biotech & Micro 18(2): 555981.
• Omid P (2024) Modern Sinus Lift Techniques: Aided by AI. Glob J Oto 26(4): 556198.
• Panahi O (2024) Bridging the Gap: AI-Driven Solutions for Dental Tissue Regeneration. Austin J Dent 11(2): 1185.
• Omid P (2024) Artificial Intelligence in Oral Implantology, Its Applications, Impact and Challenges. Adv Dent & Oral Health 17(4): 555966.
• Omid P (2024) Empowering Dental Public Health: Leveraging Artificial Intelligence for Improved Oral Healthcare Access and Outcomes. JOJ Pub Health 9(1): 555754.
• Omid Panahi (2024) AI: A New Frontier in Oral and Maxillofacial Surgery. Acta Scientific Dental Sciences 8(6): 40-42.
• Omid Panahi (2024) Teledentistry: Expanding Access to Oral Healthcare. Journal of Dental Science Research Reviews & Reports. SRC/JDSR-203.
• Omid Panahi (2024) Artificial Intelligence: A New Frontier in Periodontology. Mod Res Dent 8(1): 000680.
• Omid Panahi (2024) AI Ushering in a New Era of Digital Dental-Medicine. Acta Scientific Medical Sciences 8(8): 131-134.
• Panahi O, Farrokh (2025) The Use of Machine Learning for Personalized Dental-Medicine Treatment. Glob J Med Biomed Case Rep 1: 001.
• Omid Panahi, Sevil Farrokh (2025) Building Healthier Communities: The Intersection of AI, IT, and Community Medicine. Int J Nurs Health Care 1(1): 1-4.
• Omid Panahi, Ali Ezzati (2025) AI in Dental-Medicine: Current Applications & Future Directions. Open Access J Clin Images. 2(1): 1-5.